Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin
Trends Mol Med. 2023 Dec 19:S1471-4914(23)00280-0. doi: 10.1016/j.molmed.2023.12.001. Online ahead of print.ABSTRACTThe neurobiology of eating disorders [EDs; anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] remains poorly understood. Here, I describe how neuroimaging, accompanied by peripheral endocrine measures, can provide insights into the neurobiological drivers of eating disorders. Orexins/hypocretins, glucagon-like peptide-1 receptor (GLP1R) agonists, and psilocybin are highlighted as avenues for investigation.PMID:38123380 | DOI:10.1016/j.molmed.2023.12.001 (Source: Molecular Medicine)
Source: Molecular Medicine - December 20, 2023 Category: Molecular Biology Authors: Trevor Steward Source Type: research
Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin
Trends Mol Med. 2023 Dec 19:S1471-4914(23)00280-0. doi: 10.1016/j.molmed.2023.12.001. Online ahead of print.ABSTRACTThe neurobiology of eating disorders [EDs; anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] remains poorly understood. Here, I describe how neuroimaging, accompanied by peripheral endocrine measures, can provide insights into the neurobiological drivers of eating disorders. Orexins/hypocretins, glucagon-like peptide-1 receptor (GLP1R) agonists, and psilocybin are highlighted as avenues for investigation.PMID:38123380 | DOI:10.1016/j.molmed.2023.12.001 (Source: Trends in Molecular Medicine)
Source: Trends in Molecular Medicine - December 20, 2023 Category: Molecular Biology Authors: Trevor Steward Source Type: research
Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin
Trends Mol Med. 2023 Dec 19:S1471-4914(23)00280-0. doi: 10.1016/j.molmed.2023.12.001. Online ahead of print.ABSTRACTThe neurobiology of eating disorders [EDs; anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] remains poorly understood. Here, I describe how neuroimaging, accompanied by peripheral endocrine measures, can provide insights into the neurobiological drivers of eating disorders. Orexins/hypocretins, glucagon-like peptide-1 receptor (GLP1R) agonists, and psilocybin are highlighted as avenues for investigation.PMID:38123380 | DOI:10.1016/j.molmed.2023.12.001 (Source: Trends in Molecular Medicine)
Source: Trends in Molecular Medicine - December 20, 2023 Category: Molecular Biology Authors: Trevor Steward Source Type: research
Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin
Trends Mol Med. 2023 Dec 19:S1471-4914(23)00280-0. doi: 10.1016/j.molmed.2023.12.001. Online ahead of print.ABSTRACTThe neurobiology of eating disorders [EDs; anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] remains poorly understood. Here, I describe how neuroimaging, accompanied by peripheral endocrine measures, can provide insights into the neurobiological drivers of eating disorders. Orexins/hypocretins, glucagon-like peptide-1 receptor (GLP1R) agonists, and psilocybin are highlighted as avenues for investigation.PMID:38123380 | DOI:10.1016/j.molmed.2023.12.001 (Source: Trends in Molecular Medicine)
Source: Trends in Molecular Medicine - December 20, 2023 Category: Molecular Biology Authors: Trevor Steward Source Type: research
Impact of the COVID-19 pandemic on eating disorder-related hospital and programme admissions in youth
Commentary on: Hartman-Munick SM, Lin JA, Milliren CE, et al. Association of the COVID-19 pandemic with adolescent and young adult eating disorder care volume. JAMA Pediatr. 2022 Dec 1;176(12):1225-1232. doi: 10.1001/jamapediatrics.2022.4346. Implications for practice and research The current research demonstrates the need to increase staffing and programme capacity for those working with patients with eating disorders (EDs) to ensure adequate care. Future research into how the relationship between ED-related hospitalisations and individual external factors, such as social isolation are needed. Context Research has shown t...
Source: Evidence-Based Nursing - December 15, 2023 Category: Nursing Authors: Devoe, D. J., Holland, K. M. G. Tags: Child health, COVID-19 Source Type: research
Herpetic Whitlow Associated With an Eating Disorder: A Case Report
Cureus. 2023 Nov 11;15(11):e48654. doi: 10.7759/cureus.48654. eCollection 2023 Nov.ABSTRACTHerpetic whitlow is a localized cutaneous viral infection primarily affecting the fingers, caused by herpes simplex virus types 1 (HSV-1) or 2 (HSV-2). It can be recurrent due to behavioral factors associated with eating disorders, such as bulimia nervosa. We would like to introduce "Jehany Sign," suggesting the term for the association of bulimia nervosa with HSV infections. Here, we present the case of a 50-year-old pre-diabetic female with recurrent herpetic whitlow on her left index finger associated with self-induced vomiting an...
Source: Herpes - December 13, 2023 Category: Infectious Diseases Authors: Fawaz H Aljehani Abdullah M Alharthi Amal W AlDoboke Ammar A Bakhsh Amjad Z Alharbi Source Type: research
Risk of positive screening for anorexia nervosa, bulimia nervosa and night eating syndrome and associated risk factors in medical fellows in Northeastern Mexico: a multicenter study
ConclusionsThere was a higher risk of positive screening for AN or BN and NES in UMI and MR in our population. In the case of MR, those in first year have a higher risk of AN and BN. Timely diagnosis and treatment are mandatory in this population. (Source: Journal of Eating Disorders)
Source: Journal of Eating Disorders - December 7, 2023 Category: Eating Disorders & Weight Management Source Type: research
